Loading...
Header Logo
Keywords
Last Name
Institution

GARY BRANDON GUNN

TitleAssociate Professor
InstitutionMD Anderson
DepartmentRadiation Oncology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gunn GB, Mendoza TR, Garden AS, Wang XS, Shi Q, Morrison WH, Frank SJ, Phan J, Fuller CD, Chambers MS, Hanna EY, Lu C, Rosenthal DI, Cleeland CS. Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Support Care Cancer. 2019 Apr 29. PMID: 31037378.
      View in: PubMed
    2. Kiser K, Meheissen MAM, Mohamed ASR, Kamal M, Ng SP, Elhalawani H, Jethanandani A, He R, Ding Y, Rostom Y, Hegazy N, Bahig H, Garden A, Lai S, Phan J, Gunn GB, Rosenthal D, Frank S, Brock KK, Wang J, Fuller CD. Prospective quantitative quality assurance and deformation estimation of MRI-CT image registration in simulation of head and neck radiotherapy patients. Clin Transl Radiat Oncol. 2019 Sep; 18:120-127. PMID: 31341987.
      View in: PubMed
    3. Tyler MA, Mohamed ASR, Smith JB, Aymard JM, Fuller CD, Phan J, Frank SJ, Ferrarotto R, Kupferman ME, Hanna EY, Gunn GB, Su SY. Long-term quality of life after definitive treatment of sinonasal and nasopharyngeal malignancies. Laryngoscope. 2019 Feb 01. PMID: 30706478.
      View in: PubMed
    4. Wu RY, Liu AY, Wisdom P, Zhu XR, Frank SJ, Fuller CD, Gunn GB, Palmer MB, Wages CA, Gillin MT, Yang J. Characterization of a new physical phantom for testing rigid and deformable image registration. J Appl Clin Med Phys. 2019 Jan; 20(1):145-153. PMID: 30580471.
      View in: PubMed
    5. Hutcheson KA, Nurgalieva Z, Zhao H, Gunn GB, Giordano SH, Bhayani MK, Lewin JS, Lewis CM. Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis. Head Neck. 2019 Feb; 41(2):479-487. PMID: 30536748.
      View in: PubMed
    6. Moreno AC, Frank SJ, Garden AS, Rosenthal DI, Fuller CD, Gunn GB, Reddy JP, Morrison WH, Williamson TD, Holliday EB, Phan J, Blanchard P. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer. Oral Oncol. 2019 Jan; 88:66-74. PMID: 30616799.
      View in: PubMed
    7. Bahig H, Yuan Y, Mohamed ASR, Brock KK, Ng SP, Wang J, Ding Y, Hutcheson K, McCulloch M, Balter PA, Lai SY, Al-Mamgani A, Sonke JJ, van der Heide UA, Nutting C, Li XA, Robbins J, Awan M, Karam I, Newbold K, Harrington K, Oelfke U, Bhide S, Philippens MEP, Terhaard CHJ, McPartlin AJ, Blanchard P, Garden AS, Rosenthal DI, Gunn GB, Phan J, Cazoulat G, Aristophanous M, McSpadden KK, Garcia JA, van den Berg CAT, Raaijmakers CPJ, Kerkmeijer L, Doornaert P, Blinde S, Frank SJ, Fuller CD. Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. Clin Transl Radiat Oncol. 2018 Nov; 13:19-23. PMID: 30386824.
      View in: PubMed
    8. Mulcahy CF, Mohamed ASR, Kanwar A, Hutcheson KA, Ghosh A, Vock D, Weber RS, Lai SY, Gunn GB, Zafereo M, Morrison WH, Ferrarotto R, Garden AS, Rosenthal DI, Fuller CD. Age-adjusted comorbidity and survival in locally advanced laryngeal cancer. Head Neck. 2018 09; 40(9):2060-2069. PMID: 29756307.
      View in: PubMed
    9. Blanchard P, Gunn GB, Lin A, Foote RL, Lee NY, Frank SJ. Proton Therapy for Head and Neck Cancers. Semin Radiat Oncol. 2018 01; 28(1):53-63. PMID: 29173756.
      View in: PubMed
    10. Mohamed ASR, Wong AJ, Fuller CD, Kamal M, Gunn GB, Phan J, Morrison WH, Beadle BM, Skinner H, Lai SY, Quinlan-Davidson SR, Belal AM, El-Gowily AG, Frank SJ, Rosenthal DI, Garden AS. Patterns of locoregional failure following post-operative intensity-modulated radiotherapy to oral cavity cancer: quantitative spatial and dosimetric analysis using a deformable image registration workflow. Radiat Oncol. 2017 Aug 15; 12(1):129. PMID: 28806994.
      View in: PubMed
    11. Pollard C, Nguyen TP, Ng SP, Frank SJ, Garden AS, Gunn GB, Fuller CD, Beadle BM, Morrison WH, Shah SJ, Wang H, Tung S, Wang C, Ginsberg LD, Zafereo ME, Sturgis EM, Su SY, Hanna EY, Rosenthal DI, Phan J. Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis. Head Neck. 2017 10; 39(10):2079-2087. PMID: 28741749.
      View in: PubMed
    12. Quinlan-Davidson SR, Mohamed ASR, Myers JN, Gunn GB, Johnson FM, Skinner H, Beadle BM, Gillenwater AM, Phan J, Frank SJ, William WN, Wong AJ, Lai SY, Fuller CD, Morrison WH, Rosenthal DI, Garden AS. Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy. Oral Oncol. 2017 09; 72:90-97. PMID: 28797467.
      View in: PubMed
    13. Reyes-Gibby CC, Melkonian SC, Wang J, Yu RK, Shelburne SA, Lu C, Gunn GB, Chambers MS, Hanna EY, Yeung SJ, Shete S. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. PLoS One. 2017; 12(7):e0180396. PMID: 28678827.
      View in: PubMed
    14. Hutcheson KA, Yuk M, Hubbard R, Gunn GB, Fuller CD, Lai SY, Lin H, Garden AS, Rosenthal DI, Hanna EY, Kies MS, Lewin JS. Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: A cohort analysis and literature review. Head Neck. 2017 08; 39(8):1516-1523. PMID: 28452175.
      View in: PubMed
    15. Reyes-Gibby CC, Melkonian SC, Hanna EY, Yeung SJ, Lu C, Chambers MS, Banala SR, Gunn GB, Shete SS. Cohort study of oncologic emergencies in patients with head and neck cancer. Head Neck. 2017 06; 39(6):1195-1204. PMID: 28346771.
      View in: PubMed
    16. Quinlan-Davidson SR, Morrison WH, Myers JN, Gunn GB, William WN, Beadle BM, Skinner HD, Gillenwater AM, Frank SJ, Phan J, Johnson FM, Fuller CD, Zafereo ME, Rosenthal DI, Garden AS. Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapy. Head Neck. 2017 04; 39(4):633-638. PMID: 28006086.
      View in: PubMed
    17. Garden AS, Fuller CD, Rosenthal DI, William WN, Gunn GB, Beadle BM, Johnson FM, Morrison WH, Phan J, Frank SJ, Kies MS, Sturgis EM. Reply to radiotherapy for human papillomavirus-positive oropharyngeal cancers in the National Cancer Data Base. Cancer. 2016 11 15; 122(21):3411-3412. PMID: 27420634.
      View in: PubMed
    18. Wang H, Wang C, Tung S, Dimmitt AW, Wong PF, Edson MA, Garden AS, Rosenthal DI, Fuller CD, Gunn GB, Takiar V, Wang XA, Luo D, Yang JN, Wong J, Phan J. Improved setup and positioning accuracy using a three-point customized cushion/mask/bite-block immobilization system for stereotactic reirradiation of head and neck cancer. J Appl Clin Med Phys. 2016 05 08; 17(3):180-189. PMID: 27167275.
      View in: PubMed
    19. Garden AS, Fuller CD, Rosenthal DI, William WN, Gunn GB, Beadle BM, Johnson FM, Morrison WH, Phan J, Frank SJ, Kies MS, Sturgis EM. Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer. Cancer. 2016 06 01; 122(11):1702-7. PMID: 27019396.
      View in: PubMed
    20. Takiar V, Garden AS, Ma D, Morrison WH, Edson M, Zafereo ME, Gunn GB, Fuller CD, Beadle B, Frank SJ, William WN, Kies M, El-Naggar AK, Weber R, Rosenthal DI, Phan J. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys. 2016 07 15; 95(4):1117-31. PMID: 27354127.
      View in: PubMed
    21. Thaker NG, Sturdevant L, Jhingran A, Das P, Delclos ME, Gunn GB, McAleer MF, Tereffe W, Choi SL, Frank SJ, Simeone WJ, Martinez W, Hahn SM, Famiglietti R, Kuban DA. Assessing the Quality of a Radiation Oncology Case-Based, Peer-Review Program in an Integrated Academic and Community Cancer Center Network. J Oncol Pract. 2016 Apr; 12(4):e476-86. PMID: 26931402.
      View in: PubMed
    22. Edson MA, Garden AS, Takiar V, Glisson BS, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Frank SJ, Shah SJ, Tao R, William WN, Weber RS, Rosenthal DI, Phan J. Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy. Head Neck. 2016 04; 38 Suppl 1:E2091-9. PMID: 26920665.
      View in: PubMed
    23. Gunn GB, Blanchard P, Garden AS, Zhu XR, Fuller CD, Mohamed AS, Morrison WH, Phan J, Beadle BM, Skinner HD, Sturgis EM, Kies MS, Hutcheson KA, Rosenthal DI, Mohan R, Gillin MT, Frank SJ. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):360-7. PMID: 27084653.
      View in: PubMed
    24. Cabanillas ME, Dadu R, Hu MI, Lu C, Gunn GB, Grubbs EG, Lai SY, Williams MD. Thyroid Gland Malignancies. Hematol Oncol Clin North Am. 2015 Dec; 29(6):1123-43. PMID: 26568552.
      View in: PubMed
    25. Nien HH, Sturgis EM, Kies MS, El-Naggar AK, Morrison WH, Beadle BM, Johnson FM, Gunn GB, Fuller CD, Phan J, Gold KA, Frank SJ, Skinner H, Rosenthal DI, Garden AS. Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus-associated oropharyngeal cancer. Head Neck. 2016 04; 38 Suppl 1:E1554-61. PMID: 26595157.
      View in: PubMed
    26. Shoultz-Henley S, Garden AS, Mohamed AS, Sheu T, Kroll MH, Rosenthal DI, Gunn GB, Hayes AJ, French C, Eichelberger H, Kalpathy-Cramer J, Smith BD, Phan J, Ayoub Z, Lai SY, Pham B, Kies M, Gold KA, Sturgis E, Fuller CD. Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation. Int J Cancer. 2016 Mar 01; 138(5):1290-7. PMID: 26414107.
      View in: PubMed
    27. Ding Y, Hazle JD, Mohamed AS, Frank SJ, Hobbs BP, Colen RR, Gunn GB, Wang J, Kalpathy-Cramer J, Garden AS, Lai SY, Rosenthal DI, Fuller CD. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study. NMR Biomed. 2015 Dec; 28(12):1645-54. PMID: 26451969.
      View in: PubMed
    28. Gunn GB, Hansen CC, Garden AS, Fuller CD, Mohamed AS, Morrison WH, Frank SJ, Beadle BM, Phan J, Chronowski GM, Sturgis EM, Lewis CM, Lu C, Hutcheson KA, Mendoza TR, Cleeland CS, Rosenthal DI. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. Radiother Oncol. 2015 Oct; 117(1):132-8. PMID: 26403258.
      View in: PubMed
    29. Holliday EB, Esmaeli B, Pinckard J, Garden AS, Rosenthal DI, Morrison WH, Kies MS, Gunn GB, Fuller CD, Phan J, Beadle BM, Zhu XR, Zhang X, Frank SJ. A Multidisciplinary Orbit-Sparing Treatment Approach That Includes Proton Therapy for Epithelial Tumors of the Orbit and Ocular Adnexa. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):344-52. PMID: 26454680.
      View in: PubMed
    30. Takiar V, Ma D, Garden AS, Li J, Rosenthal DI, Beadle BM, Frank SJ, Fuller CD, Gunn GB, Morrison WH, Hutcheson K, El-Naggar AK, Gold KA, Kupferman ME, Phan J. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy. Head Neck. 2016 04; 38 Suppl 1:E925-33. PMID: 25994561.
      View in: PubMed
    31. Hutcheson KA, Yuk MM, Holsinger FC, Gunn GB, Lewin JS. Late radiation-associated dysphagia with lower cranial neuropathy in long-term oropharyngeal cancer survivors: video case reports. Head Neck. 2015 Apr; 37(4):E56-62. PMID: 25043608.
      View in: PubMed
    32. Greco A, Orlandi E, Mirabile A, Takanen S, Fallai C, Iacovelli NA, Rimedio A, Russi E, Sala M, Monzani D, Rosenthal DI, Gunn GB, Steca P, Licitra L, Bossi P. Italian version of the M.D. Anderson Symptom Inventory--Head and Neck Module: linguistic validation. Support Care Cancer. 2015 Dec; 23(12):3465-72. PMID: 25791393.
      View in: PubMed
    33. Lewis CM, Chronowski GM, Dong W, Gunn GB, Rosenthal DI, Weber RS. Analysis of Charges Associated with Definitive Nonsurgical Therapy for Early-Stage Lateralized Tonsil Cancer. Ann Surg Oncol. 2015 Aug; 22(8):2755-60. PMID: 25519929.
      View in: PubMed
    34. Sturgeon JD, Cox JA, Mayo LL, Gunn GB, Zhang L, Balter PA, Dong L, Awan M, Kocak-Uzel E, Mohamed AS, Rosenthal DI, Fuller CD. Improved human observer performance in digital reconstructed radiograph verification in head and neck cancer radiotherapy. Int J Comput Assist Radiol Surg. 2015 Oct; 10(10):1667-73. PMID: 25477277.
      View in: PubMed
    35. Tang C, Fuller CD, Garden AS, Awan MJ, Colen RR, Morrison WH, Frank SJ, Beadle BM, Phan J, Sturgis EM, Zafereo ME, Weber RS, Rosenthal DI, Gunn GB. Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response. Oral Oncol. 2015 Feb; 51(2):195-201. PMID: 25444304.
      View in: PubMed
    36. Mohamed AS, Ruangskul MN, Awan MJ, Baron CA, Kalpathy-Cramer J, Castillo R, Castillo E, Guerrero TM, Kocak-Uzel E, Yang J, Court LE, Kantor ME, Gunn GB, Colen RR, Frank SJ, Garden AS, Rosenthal DI, Fuller CD. Quality assurance assessment of diagnostic and radiation therapy-simulation CT image registration for head and neck radiation therapy: anatomic region of interest-based comparison of rigid and deformable algorithms. Radiology. 2015 Mar; 274(3):752-63. PMID: 25380454.
      View in: PubMed
    37. Hanna EY, Mendoza TR, Rosenthal DI, Gunn GB, Sehra P, Yucel E, Cleeland CS. The symptom burden of treatment-naive patients with head and neck cancer. Cancer. 2015 Mar 01; 121(5):766-73. PMID: 25369213.
      View in: PubMed
    38. Walker GV, Awan M, Tao R, Koay EJ, Boehling NS, Grant JD, Sittig DF, Gunn GB, Garden AS, Phan J, Morrison WH, Rosenthal DI, Mohamed AS, Fuller CD. Prospective randomized double-blind study of atlas-based organ-at-risk autosegmentation-assisted radiation planning in head and neck cancer. Radiother Oncol. 2014 Sep; 112(3):321-5. PMID: 25216572.
      View in: PubMed
    39. Sheu T, Fuller CD, Mendoza TR, Garden AS, Morrison WH, Beadle BM, Phan J, Frank SJ, Hanna EY, Lu C, Cleeland CS, Rosenthal DI, Gunn GB. Nomogram for predicting symptom severity during radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg. 2014 Oct; 151(4):619-26. PMID: 25104816.
      View in: PubMed
    40. Garden AS, Gunn GB, Hessel A, Beadle BM, Ahmed S, El-Naggar AK, Fuller CD, Byers LA, Phan J, Frank SJ, Morrison WH, Kies MS, Rosenthal DI, Sturgis EM. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer. Cancer. 2014 Oct 01; 120(19):3082-8. PMID: 24898672.
      View in: PubMed
    41. Awan MJ, Mohamed AS, Lewin JS, Baron CA, Gunn GB, Rosenthal DI, Holsinger FC, Schwartz DL, Fuller CD, Hutcheson KA. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: a preliminary dosimetric comparison. Oral Oncol. 2014 Aug; 50(8):746-52. PMID: 24906528.
      View in: PubMed
    42. Frank SJ, Cox JD, Gillin M, Mohan R, Garden AS, Rosenthal DI, Gunn GB, Weber RS, Kies MS, Lewin JS, Munsell MF, Palmer MB, Sahoo N, Zhang X, Liu W, Zhu XR. Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):846-53. PMID: 24867532.
      View in: PubMed
    43. Kocak-Uzel E, Gunn GB, Colen RR, Kantor ME, Mohamed AS, Schoultz-Henley S, Mavroidis P, Frank SJ, Garden AS, Beadle BM, Morrison WH, Phan J, Rosenthal DI, Fuller CD. Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy. Radiother Oncol. 2014 May; 111(2):281-8. PMID: 24746582.
      View in: PubMed
    44. Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014 Jul 01; 120(13):1975-84. PMID: 24711162.
      View in: PubMed
    45. Blevins DP, Dadu R, Hu M, Baik C, Balachandran D, Ross W, Gunn B, Cabanillas ME. Aerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer. Thyroid. 2014 May; 24(5):918-22. PMID: 24635127.
      View in: PubMed
    46. Baron CA, Awan MJ, Mohamed AS, Akel I, Rosenthal DI, Gunn GB, Garden AS, Dyer BA, Court L, Sevak PR, Kocak-Uzel E, Fuller CD. Estimation of daily interfractional larynx residual setup error after isocentric alignment for head and neck radiotherapy: quality assurance implications for target volume and organs-at-risk margination using daily CT on- rails imaging. J Appl Clin Med Phys. 2014 Jan 08; 16(1):5108. PMID: 25679151.
      View in: PubMed
    47. Skinner HD, Sturgis EM, Klopp AH, Ang KK, Rosenthal DI, Garden AS, Morrison WH, Gunn GB, Beadle BM. Clinical characteristics of patients with multiple potentially human papillomavirus-related malignancies. Head Neck. 2014 Jun; 36(6):819-25. PMID: 23720126.
      View in: PubMed
    48. Gunn GB, Frank SJ. Advances in radiation oncology for the management of oropharyngeal tumors. Otolaryngol Clin North Am. 2013 Aug; 46(4):629-43. PMID: 23910474.
      View in: PubMed
    49. Sanguineti G, Rao N, Gunn B, Ricchetti F, Fiorino C. Predictors of PEG dependence after IMRT±chemotherapy for oropharyngeal cancer. Radiother Oncol. 2013 Jun; 107(3):300-4. PMID: 23773408.
      View in: PubMed
    50. Gunn GB, Debnam JM, Fuller CD, Morrison WH, Frank SJ, Beadle BM, Sturgis EM, Glisson BS, Phan J, Rosenthal DI, Garden AS. The impact of radiographic retropharyngeal adenopathy in oropharyngeal cancer. Cancer. 2013 Sep 01; 119(17):3162-9. PMID: 23733178.
      View in: PubMed
    51. Yang J, Beadle BM, Garden AS, Gunn B, Rosenthal D, Ang K, Frank S, Williamson R, Balter P, Court L, Dong L. Auto-segmentation of low-risk clinical target volume for head and neck radiation therapy. Pract Radiat Oncol. 2014 Jan-Feb; 4(1):e31-7. PMID: 24621429.
      View in: PubMed
    52. Shi Q, Mendoza TR, Gunn GB, Wang XS, Rosenthal DI, Cleeland CS. Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res. 2013 Nov; 22(9):2331-9. PMID: 23475689.
      View in: PubMed
    53. Garden AS, Kies MS, Morrison WH, Weber RS, Frank SJ, Glisson BS, Gunn GB, Beadle BM, Ang KK, Rosenthal DI, Sturgis EM. Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century. Radiat Oncol. 2013 Jan 29; 8:21. PMID: 23360540.
      View in: PubMed
    54. Awan M, Kalpathy-Cramer J, Gunn GB, Beadle BM, Garden AS, Phan J, Holliday E, Jones WE, Maani E, Patel A, Choi J, Clyburn V, Tantiwongkosi B, Rosenthal DI, Fuller CD. Prospective assessment of an atlas-based intervention combined with real-time software feedback in contouring lymph node levels and organs-at-risk in the head and neck: Quantitative assessment of conformance to expert delineation. Pract Radiat Oncol. 2013 Jul-Sep; 3(3):186-193. PMID: 24674363.
      View in: PubMed
    55. Gunn GB, Mendoza TR, Fuller CD, Gning I, Frank SJ, Beadle BM, Hanna EY, Lu C, Cleeland CS, Rosenthal DI. High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study. Head Neck. 2013 Oct; 35(10):1490-8. PMID: 23169304.
      View in: PubMed
    56. Garden AS, Dong L, Morrison WH, Stugis EM, Glisson BS, Frank SJ, Beadle BM, Gunn GB, Schwartz DL, Kies MS, Weber RS, Ang KK, Rosenthal DI. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):941-7. PMID: 22975604.
      View in: PubMed
    57. Hutcheson KA, Lewin JS, Barringer DA, Lisec A, Gunn GB, Moore MW, Holsinger FC. Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer. 2012 Dec 01; 118(23):5793-9. PMID: 23640737.
      View in: PubMed
    58. Sanguineti G, Sormani MP, Marur S, Gunn GB, Rao N, Cianchetti M, Ricchetti F, McNutt T, Wu B, Forastiere A. Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):235-42. PMID: 22104358.
      View in: PubMed
    59. Chronowski GM, Garden AS, Morrison WH, Frank SJ, Schwartz DL, Shah SJ, Beadle BM, Gunn GB, Kupferman ME, Ang KK, Rosenthal DI. Unilateral radiotherapy for the treatment of tonsil cancer. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):204-9. PMID: 22019242.
      View in: PubMed
    60. Kies MS, Boatright DH, Li G, Blumenschein G, El-Naggar AK, Brandon Gunn G, Lewin JS, Steinhaus GD, Sturgis EM. Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults. Head Neck. 2012 Sep; 34(9):1255-62. PMID: 22009800.
      View in: PubMed
    61. Gunn GB, Endres EJ, Parker B, Sormani MP, Sanguineti G. A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma. Strahlenther Onkol. 2010 Sep; 186(9):489-95. PMID: 20803186.
      View in: PubMed
    62. Gunn GB, Anderson KE, Patel AJ, Gallegos J, Hallberg CK, Sood G, Hatch SS, Sanguineti G. Severe radiation therapy-related soft tissue toxicity in a patient with porphyria cutanea tarda: a literature review. Head Neck. 2010 Aug; 32(8):1112-7. PMID: 19536857.
      View in: PubMed
    63. Sanguineti G, Gunn GB, Parker BC, Endres EJ, Zeng J, Fiorino C. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2011 Jan 01; 79(1):52-9. PMID: 20418027.
      View in: PubMed
    64. Sanguineti G, Gunn GB, Endres EJ, Chaljub G, Cheruvu P, Parker B. Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2008 Nov 01; 72(3):737-46. PMID: 18486356.
      View in: PubMed
    65. Krishnan S, Lin EH, Gunn GB, Chandra A, Beddar AS, Briere TM, Das P, Delclos ME, Janjan NA, Crane CH. Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases. Am J Clin Oncol. 2006 Dec; 29(6):562-7. PMID: 17148992.
      View in: PubMed
    66. Sanguineti G, Endres EJ, Gunn BG, Parker B. Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer? Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):931-8. PMID: 17011465.
      View in: PubMed
    67. Sanguineti G, Cavey ML, Endres EJ, Brandon GG, Bayouth JE. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer? Int J Radiat Oncol Biol Phys. 2006 Jan 01; 64(1):151-60. PMID: 16198066.
      View in: PubMed
    68. Gunn GB, Villa RD, Sedler RR, Hardwicke F, Fornari GA, Mark RJ. Nasopharyngeal carcinoma metastasis to the pituitary gland: a case report and literature review. J Neurooncol. 2004 May; 68(1):87-90. PMID: 15174525.
      View in: PubMed
    69. Schabath MB, Spitz MR, Hong WK, Delclos GL, Reynolds WF, Gunn GB, Whitehead LW, Wu X. A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer. 2002 Jul; 37(1):35-40. PMID: 12057865.
      View in: PubMed
    70. Schabath MB, Spitz MR, Delclos GL, Gunn GB, Whitehead LW, Wu X. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am J Ind Med. 2002 Jul; 42(1):29-37. PMID: 12111688.
      View in: PubMed
    71. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx. NMR in Biomedicine.
    72. Late radiation-associated dysphagia with lower cranial neuropathy in long-term oropharyngeal cancer survivors. Head and Neck. 37:E56-E62.
    73. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy. Head and Neck.
    74. Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus-associated oropharyngeal cancer. Head and Neck.
    75. Improved human observer performance in digital reconstructed radiograph verification in head and neck cancer radiotherapy. International Journal of Computer Assisted Radiology and Surgery. 10:1667-1673.
    76. Recurrent oral cavity cancer. Head and Neck.
    77. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope.
    78. Prospective assessment of an atlas-based intervention combined with real-time software feedback in contouring lymph node levels and organs-at-risk in the head and neck. Practical Radiation Oncology. 3:186-193.
    79. Improved setup and positioning accuracy using a three-point customized cushion/mask/bite-block immobilization system for stereotactic reirradiation of head and neck cancer. Journal of Applied Clinical Medical Physics. 17:180-189.
    80. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Practical Radiation Oncology.
    81. Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy. Head and Neck.
    82. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles. Radiotherapy and Oncology. 118:304-314.
    83. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT. Radiotherapy and Oncology. 118:315-322.
    84. Osteoradionecrosis in patients with salivary gland malignancies. Oral Oncology. 57:1-5.
    85. Complications of tympanostomy tubes in head and neck cancer patients. American Journal of Otolaryngology - Head and Neck Medicine and Surgery.
    86. Radiotherapy and Oncology. 120:48-55.
    87. Reduced acute toxicity and improved efficacy from intensitymodulated proton therapy (IMPT) for the management of head and neck cancer. Chinese Clinical Oncology. 5.
    88. In Regard to Kjems et al. International Journal of Radiation Oncology Biology Physics. 96:240.
    89. Reply to radiotherapy for human papillomavirus-positive oropharyngeal cancers in the National Cancer Data Base. Cancer. 122:3411-3412.
    90. Estimation of daily interfractional larynx residual setup error after isocentric alignment for head and neck radiotherapy. Journal of Applied Clinical Medical Physics. 16:159-169.
    91. Merkel cell carcinoma of the head and neck. Head and Neck. 38:E452-E458.
    92. CT-based volumetric tumor growth velocity. Oral Oncology. 63:16-22.
    93. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma. Cancer.
    94. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa. Radiotherapy and Oncology. 117:132-138.
    95. Methodology for analysis and reporting patterns of failure in the Era of IMRT. Radiation Oncology. 11:1.
    96. Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer. Cancer.
    97. Feeding Tube Utilization in Patients with Salivary Gland Malignancies. Otolaryngology - Head and Neck Surgery (United States). 156:109-117.
    98. Reirradiation of Head and Neck Cancers With Proton Therapy. International Journal of Radiation Oncology Biology Physics. 96:30-41.
    99. Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation. International Journal of Cancer. 138:1290-1297.
    100. Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas. Head and Neck.
    101. Linguistic validation of the Greek M.D. ANderson Symptom Inventory - Head and Neck Module. Forum of Clinical Oncology. 3:29-31.
    102. Anaplastic thyroid carcinoma. Journal of Oncology Practice. 12:511-518.
    103. Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy. Head and Neck.
    104. Quantitative body mass characterization before and after head and neck cancer radiotherapy. Oral Oncology. 61:62-69.
    105. Nasopharyngeal carcinoma metastasis to the pituitary gland. Journal of Neuro-Oncology. 68:87-90.
    106. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation. Medical Dosimetry.
    107. Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature. Scientific Reports. 6.
    108. Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma. Head and Neck.
    109. Assessing the quality of a radiation oncology case-based peer-review program in an integrated academic and community cancer center network. Journal of Oncology Practice. 12:e476-e486.
    110. Toward a model-based patient selection strategy for proton therapy. Radiotherapy and Oncology. 121:381-386.
    111. Analysis of Charges Associated with Definitive Nonsurgical Therapy for Early-Stage Lateralized Tonsil Cancer. Annals of Surgical Oncology. 22:2755-2760.
    112. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology Biology Physics.
    113. Intensity modulated proton therapy versus intensity modulated photon radiation therapy for oropharyngeal cancer. International Journal of Radiation Oncology Biology Physics. 95:1107-1114.
    114. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas. Head and Neck.
    115. Reirradiation of head and neck cancers with intensity modulated radiation therapy. International Journal of Radiation Oncology Biology Physics. 95:1117-1131.
    116. Postoperative intensity-modulated radiation therapy for head and neck cancers. 193-214.
    117. Linguistic validation of the Turkish version of the M.D. Anderson symptom inventory - Head and neck cancer module. Balkan Medical Journal. 33:339-343.
    GUNN's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description